ZYME - Zymeworks Common Stock - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ZYME is currently covered by 6 analysts with an average price target of $21.9. This is a potential upside of $10.58 (93.46%) from yesterday's end of day stock price of $11.32.

Zymeworks Common Stock's activity chart (see below) currently has 85 price targets and 80 ratings on display. The stock rating distribution of ZYME is 37.04% BUY and 62.96% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.75% with an average time for these price targets to be met of 185.92 days.

Highest price target for ZYME is $28, Lowest price target is $13, average price target is $19.33.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 10-Mar-2025. First documented stock forecast 24-May-2017.

Currently out of the existing stock ratings of ZYME, 10 are a BUY (37.04%), 17 are a HOLD (62.96%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$13

$0.04 (0.31%)

$12

1 months 29 days ago
(10-Mar-2025)

16/17 (94.12%)

$1.9 (17.12%)

74

Hold

$14

$1.04 (8.02%)

$12

4 months 20 days ago
(19-Dec-2024)

5/5 (100%)

$0.42 (3.09%)

166

Buy

$18

$5.04 (38.89%)

$11

4 months 23 days ago
(16-Dec-2024)

3/4 (75%)

$4.23 (30.72%)

73

Buy

$25

$12.04 (92.90%)

$12

6 months 2 days ago
(07-Nov-2024)

4/12 (33.33%)

$8.23 (49.08%)

62

Buy

$18

$5.04 (38.89%)

$16

6 months 5 days ago
(04-Nov-2024)

7/14 (50%)

$3.24 (21.95%)

247

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ZYME (Zymeworks Common Stock) average time for price targets to be met?

On average it took 185.92 days on average for the stock forecasts to be realized with a an average price target met ratio 69.75

Which analyst has the current highest performing score on ZYME (Zymeworks Common Stock) with a proven track record?

JIM BIRCHENOUGH

Which analyst has the most public recommendations on ZYME (Zymeworks Common Stock)?

Jim Birchenough works at WELLS FARGO and has 10 price targets and 4 ratings on ZYME

Which analyst is the currently most bullish on ZYME (Zymeworks Common Stock)?

David Novak with highest potential upside - $61.04

Which analyst is the currently most reserved on ZYME (Zymeworks Common Stock)?

Gena Wang with lowest potential downside - -$3.96

Zymeworks Common Stock in the News

Zymeworks Inc. (ZYME): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout

We recently published a list of 20 Stocks Insiders Bought in April After Trump’s Tariff Rollout. In this article, we are going to take a look at where Zymeworks Inc. (NASDAQ:ZYME) stands against other stocks that insiders bought in April after Trump’s tariff rollout. President Donald Trump called April 2 a “Liberation Day” after signing...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?